| PABGX | VIGRX | PABGX / VIGRX | |
| Total Expense Ratio | 0.95 | 0.17 | 559% |
| Annual Report Gross Expense Ratio | 0.95 | 0.17 | 559% |
| Fund Existence | 26 years | 33 years | - |
| Gain YTD | 17.875 | 19.116 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 69.6B | 357B | 19% |
| Annual Yield % from dividends | 0.00 | 0.30 | - |
| Returns for 1 year | 7.04 | 18.43 | 38% |
| Returns for 3 years | 83.99 | 109.68 | 77% |
| Returns for 5 years | 31.66 | 99.19 | 32% |
| Returns for 10 years | 181.89 | 346.70 | 52% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MODL | 47.53 | 0.15 | +0.31% |
| VictoryShares WestEnd U.S. Sector ETF | |||
| GSLC | 132.06 | 0.21 | +0.16% |
| Goldman Sachs ActiveBeta® US LgCp Eq ETF | |||
| FIRS | 23.08 | N/A | N/A |
| FIRE Funds Wealth Builder ETF | |||
| HSCZ | 38.71 | -0.02 | -0.06% |
| iShares Currency Hdgd MSCI EAFE SmCp ETF | |||
| BBP | 77.29 | -0.86 | -1.10% |
| Virtus LifeSci Biotech Products ETF | |||